Health News

Insight into the dazzling impact of insulin in cells
Tuesday, May 21, 2013 - 09:37

Australian scientists have charted the path of insulin action in cells in precise detail like never before. This provides a comprehensive blueprint for understanding what goes wrong in diabetes.

 

Read more
Nano-messenger opens way for new cancer treatment
Tuesday, May 21, 2013 - 09:25

A new study from Karolinska Institutet shows that exosomes, nanoparticles that transmit information between cells, constitute a potential new treatment strategy for several cancers. The study, which was conducted on mice, was published recently online in the scientific journal Cancer Research.

 

Read more
Youth bullying because of perceived sexual orientation widespread and damaging
Monday, May 20, 2013 - 14:20

Bullying because of perceived sexual orientation is prevalent among school-aged youths, according to a study led by Donald Patrick, professor of health services at the UW School of Public Health.  The study was published online May 16 in the American Journal of Public Health.

 

Read more
SUMO wrestling cells reveal new protective mechanism target for stroke
Monday, May 20, 2013 - 11:06

Scientists investigating the interaction of a group of proteins in the brain responsible for protecting nerve cells from damage have identified a new target that could increase cell survival.

 

Read more
First Long-Term Study Reveals Link Between Childhood ADHD and Obesity
Monday, May 20, 2013 - 10:38

A new study conducted by researchers at the Child Study Center at NYU Langone Medical Center found men diagnosed as children with attention-deficit/hyperactivity disorder (ADHD) were twice as likely to be obese in a 33-year follow-up study compared to men who were not diagnosed with the condition. The study appears in the May 20 online edition of Pediatrics.

 

Read more
PARP Inhibitor Shows Activity in Pancreatic, Prostate Cancers Among Patients Carrying BRCA Mutations
Friday, May 17, 2013 - 13:00

In the largest clinical trial to date to examine the efficacy of PARP inhibitor therapy in BRCA 1/2 carriers with diseases other than breast and ovarian cancer, the oral drug olaparib was found to be effective against advanced pancreatic and prostate cancers. Results of the study, led by researchers from the Perelman School of Medicine at the University of Pennsylvania and Sheba Medical Center in Tel Hashomer, Israel, will be presented during the American Society of Clinical Oncology’s annual meeting in Chicago in early June (Abstract #11024).

 

Read more